Introduction
Over the past decade this unit has maintained an interest in Kaposi's sarcoma (KS) in this region, Nigeria's most southeastern state. It forms a belt with neighbouring Cameroun of relatively high endemicity and the lesion accounts for 15-20% of malignant tumours (unpublished work). Furthermore, while most patients with malignant disease generally present late and have a poor prognosis, some patients with advanced KS show a favourable response to cytotoxic drug therapy, a clinical observation which has increased our interest in this disease.
KS was first described in 1872 by an Austrian dermatologist, Moritz Kohn Kaposi1, but the largest number of KS patients have been seen in Equatorial Africa -Eastern Zaire, Uganda and Nigeria2 being examples. There seem to be variations in the clinical manifestation of the disease in countries of this region; however, the total number of patients seen greatly exceeds the number seen in all other continents. Since 1981 KS has been seen in increasing numbers of young American male homosexuals, and its reported association with a state of depressed cellular immunity has been of considerable interest in tropical Africa. In these KS patients depression of cellular immunity manifests as lymphopenia with an abnormal T4/T8 ratio reflecting absolute depletion of T4 cells, cutaneous anergy, and infection with a variety of organisms including protozoans, yeasts, bacteria and a range ofviruses; this clinicopathological picture is called the acquired immunodeficiency syndrome (AIDS). Knowledge of the immunological status of KS patients in tropical Africa has remained largely fragmentary and incomplete3.
The present study has examined in detail evidence of infection with the agents HTLV-III/LAV, CMV, EBV, HBV, HAV and Candida albicans. The chemotactic locomotion of peripheral blood monocytes towards casein was assayed in both tumour patients and normal controls as well as the ability by the test groups to make delayed-type hypersensitivity reaction to tuberculin.
Materials and methods
Patients: The study was conducted in the period January 1978 to December 1982 during which 27 adult male patients with KS attended the University of Calabar Teaching Hospital (UCTH) and a further 10 male patients were seen in consultation in 4 other hospitals within the district; their ages ranged from 18 to 55 years (mean 30 years). Thirty patients, 25 male and 5 female, aged 28-55 years (mean 35 years), with histologically proven primary cell carcinoma of the liver (PCL), served as the positive control group. Negative control was provided by 150 young adults who attended the outpatients department for minor ailments such as malaria and abdominal discomfort attributable to intestinal helminthiasis: all were non-icteric and had no previous history of jaundice; 107 were male and 43 female, their ages ranging from 18 to 60 years (mean 40 years). Cells for chemotaxis assay: Previous work4 has shown that malignant tumours depress host macrophage functions and that human blood monocytes are suitable for mononuclear phagocyte chemotaxis assays5.
Human monocytes were obtained from freshly collected heparinized blood. The red blood cells were sedimented for one hour with dextran (molecular weight 110 000) in physiological (0.9% NaCl) saline (Fisons, Loughborough) in the ratio of 1 ml dextran per 10 ml of blood. The leukocyte-rich top layer was withdrawn and layered on to Ficoll-Triosil 440 (Pharmacia, Uppsala and Nyegaard, Oslo) separating mixture and spun at 500 x g for 30 min. The separated monocytes and neutrophils were collected, washed once and resuspended in Gey's solution at a concentration of 106 cells/ml. contained Gey's solution only, whereas tests contained casein 1 mg/ml (Merck, Darmstadt). The method allows cells in an upper chamber to migrate through the pores of a membrane filter in a gradient of test substance diffusing from a lower chamber. Micropore filters (Millipore, Bedford, Massachusetts and Sartorius, Gottingen, Germany) (8 pm pore size) were used; the incubation time was 130 min. Duplicate chambers containing each test agent were set up in all the experiments. Cell migration was measured by estimating the distance in micrometers migrated by the leading front cells. The results were expressed as the means of 10 such readings per test. Results were considered significant only if the mean migration ofcells towards the test agent differed from that towards the negative control by 10 ,um or more.
The difference was usually statistically significant.
Tuberculin test: Old tuberculin was introduced into the skin of the forearm by a multiple (6) puncture spring release gun. A positive reaction is shown by the development of an area of redness and swelling in the skin around the site of introduction of the tuberculoprotein, reaching a maximum usually at 72 hours. In this region of Nigeria, 90-95% of adults give a positive reaction to tuberculin.(unpublished observation). The area of redness and infiltration at 72 hours was measured in two diameters at right angles to one another by means ofcallipers (Asschem, Falkirk).
Serological assays: Serum samples were obtained from three groups of subjects -37 male KS patients, 30 PCL patients (25 male, 5 female), and 150 healthy young adults (107 male, 43 female).
The sera were frozen until testing or transfer to West Germany where the ELISA testing was done.
Assays for hepatitis B surface antigen (HBiAg), hepatitis B core antibody (anti-HB,), hepatitis B surface antibody (anti-HB) and hepatitis A antibody were by radioimmunoassay (RIA; Abbott Laboratories, Chicago, USA). Specimens which were positive for HB,Ag were also examined for hepatitis E antigen and antibody (HB,Ag and anti-HB.). All specimens were also tested for EBV and CMV. Slides of suspected candidiasis were stained with the Gram stain.
Histology: Paraffin sections of tumours were stained with haematoxylin and eosin (H & E).
Results
Clinical presentation of KS: In tropical Africa KS patients usually present late, in very poor general condition and with severe anaemia and gross sepsis. The lower extremities are most frequently affected, characteristically bearing enormous fungating malodorous tumours measuring several centimetres in diameter ( Figure 1A,B ). Gangrene of the feet and legs requiring amputation not infrequently occurs. These large lesions usually occur in association with nodules varying in size and stage of development; the nodules are characteristically bluishblack or purplish in colour (Figure 2A,b ). Massive lymphoedema of the affected legs is common, as is their symmetrical involvement ( Figure 3) . Occasionally, the upper extremities may be affected ( Figure 4 ) and here again the symmetrical distribution of this tumour can be seen.
Histologically two components predominate: bands of spindle cells embedded in a network of Figure 5 ). HTL V-IIILA V serology: Of the 217 serum samples assayed by ELISA, none was positive for anti-HTLV-III/LAV. Ten of the 37 KS patients received multiple blood transfusion in the course of treatment (blood is at present not screened for anti-HTLV-III/LAV in most regions of tropical Africa). It was of interest to test these patients before and after multiple transfusion: no antibody seroconversion occurred. Negative control: Gey's solution = 40 + 1. Chemotactic locomotion of peripheral blood monocytes towards casein: The chemotactic migration of peripheral blood monocytes towards the known chemoattractant casein (at a constant concentration of 1 mg/ml) was assayed. Table 1 shows the strikingly reduced locomotion of KS monocytes towards casein in comparison with monocytes from normal non-tumour-bearing subjects. A similar reduction in migration was seen in monocytes from PCL patients in the same chemotaxis assay. The observed reduction in KS monocyte chemotactic activity was not related to the clinical stage of the disease process; monocytes exhibited marked reduction in locomotive capacity whether the cells were obtained from patients with massive fungating tumours (such as in Figure 1 ) or those with multiple cutaneous nodules only. This applied also to PCL patients.
Delayed-type hypersensitivity skin reaction: In man, a state of hypersensitivity to tuberculoprotein develops as a result of tuberculous infection (clinical) or previous contact with the tubercle bacillus. This allergic state persists for years, even in the absence of further contact with the tubercle bacillus. It is demonstrable in a variety of ways in all of which tuberculoprotein is applied to or injected into the skin. These procedures, known as tuberculin tests, constitute the paradigm ofthe delayed-type bacterial hypersensitivity reaction.
The mean size of the delayed-type hypersensitivity cutaneous reaction as judged by the area oferythema and induration at 72 hours was 15 mm and persisted for 12 days in normal subjects ( Table 2) , but was much smaller and shortlived in KS and PCL patients. Furthernore, cutaneous reactivity to tuberculin could not be demonstrated in 7 of the 37 KS patients. The inability to elicit reactivity was reproducible when graded and increasing amounts of tuberculin (0.1 ml of a 1 in 10 000 dilution of old tuberculin, 0.1 ml of a 1 in 1000 and 0.1 ml of 1 in 100 dilution) were injected intradermally (Mantoux test), an equivalent injection of glycerin broth into the other arm providing the control.
Prevalence of markers of previous viral infections:
Twelve specimens from normal subjects were definitely positive for HB.Ag out of 150 sera tested (8%) ( and one of these had no other markers of hepatitis B infection and another was positive for anti-HBC; these two specimens were excluded. By contrast, all KS and PCL patients had high circulatory antibody levels to both HBC and HB5 compared with 71/136 and 50/135 respectively for normal subjects. The sera were also tested for the presence of hepatitis A antibody: specimens from all 150 normal subjects and all patients (both KS and PCL) were positive. All specimens from tumour-bearing patients (both KS and PCL) were positive for CMV and EBV, compared with 11 and 9 respectively from 37 controls. Candida albicans infection: The diagnosis ofmucosal lesions (buccal cavity and vaginal) was readily made by the examination of Gram-stained films, the oval budding bodies being highly characteristic. Thrush was diagnosed and Candida albicans isolated from the white patches characteristic of this condition in 30 out of 37 KS patients, and in all 30 PCL patients including the 5 PCL females who presented with intense irritation of the vulva and vagina. There was no clinical evidence of candidiasis in any of the normal subjects.
Discussion
As is generally typical of tropical presentation, the patients with KS reported here had advanced disease, coming to hospital at a stage when very little could be done for them. However, they demonstrate certain clinical features of KS which are strikingly different from those described in previous accounts of the same disease state in various parts of equatorial Africa.
First, every patient studied had cutaneous disease affecting only the limbs. This contrasts with several other studies which have emphasized that the disease in black Africans frequently involves the visceral organs and that often this is the first and only manifestation of KS. The impression has been that the gastrointestinal tract is the most frequently affected internal organ; other parts of the body known to be involved include the lungs, the heart, liver, adrenals and abdominal lymph nodes8'9. It has been estimated that in over 10% of black African patients with KS there is visceral involvement9.
Secondly, not a single child with KS was seen in the present series; the youngest patient was 18 years and the oldest 55 years (mean age 30). Yet Marshall10 noted that in tropical Africa KS is more common in children than adults, and Domonkos8 has described how in Bantu children massive involvement of the lymph nodes, especially cervical nodes, precedes the appearance of skin lesions. The children also develop lesions in the eyelids and conjunctiva from which masses of haemorrhagic tissue hang down. MacDonald and Kelly9, however, observed two age-related peaks in the occurrence of KS in male black Africansthe first decade of life and the 50-54 year age group.
Thirdly, all patients in the present study were male. This finding is in agreement with a previous study from Nigeria2 of 29 cases of KS, all in males. The lesions were mainly on the limbs and the patients came from one region, the mid-western belt now known as Bendel State. Other accounts of the male:female incidence of KS consistently emphasize that males are affected more frequently than females, and the male to female ratios reported vary from 2:1 in the Bantu of Southern Africa to 33:1 in Ugandan Africans9.
The results of the present study clearly show that Nigerian KS is not associated with infection by HTLV-Im/LAV as determined by the ELISA tests. Similar results were reported in 14 patients with KS, aged 14-64 years, at Fomulac Hospital, Zaire"1, none of whom had antibodies against HTLV-Ill/LAV on ELISA testing.
Depression of peripheral blood monocyte chemotaxis and a diminished delayed-type hypersensitivity reaction to tuberculin were uniformly shown by both KS and PCL patients, supporting the results of previous studies by several workers"2 -6. The mechanisms proposed for this effect include the production of factors which mediate depression of mononuclear phagocyte function in animals and humans with malignant tumours'7.
All patients (both KS and PCL) had circulating antibodies to CMV, EBV, HBV and HAV. By contrast, the prevalence of infection in normal controls varied considerably from 24% for EBV to 1000/% for HAV. Similar studies from Zambia showed seropositivity to CMV in 100% of controls3. The relatively high prevalence of HBV in the present study is at variance with the Zambian findings.
Gallo and co-workers'8 have provided convincing evidence that a T-cell lymphotropic retrovirus, HTLV-Ill, is the cause of the acquired immunodeficiency syndrome (AIDS). Gallo has further suggested that this virus originated in Africa; there are a few reports of isolation of this and related viruses from patients from Zaire"9, and of 8 African patients with AIDS seen in Paris, 6 were from Zaire, 1 from Congo and 1 from Cameroun20. The Center for Disease Control in Atlanta, Georgia, defines the clinical syndrome of AIDS as Kaposi's sarcoma and life-threatening opportunistic infections (especially by Pneumocystic carinii) in persons who have no underlying immunosuppressive disease or therapy2'-23. This definition, while clearly establishing a link between Kaposi's sarcoma and AIDS for surveillance purposes, apparently gives no clear evidence for a clinical identity of the 'endemic' form (African Kaposi's sarcoma) and the 'epidemic' variety described in greatest numbers in the USA where 3000 cases were reported between June and December 198324. The exponential rise and its predominance in the major metropolitan areas of the USA among homosexual and bisexual males, intravenous drug abusers, haemophiliacs and recipients of blood transfusions is of note. Tropical African KS patients in the present study reproducibly failed to show anti-HTLV-III/LAV antibody. Endemic tropical African KS and epidemic AIDS-linked KS seems to be two different diseases with possibly different aetiological agents.
